Ghana made history on Tuesday, October 7, 2025, by introducing the Human Papillomavirus (HPV) vaccine into its national ...

Human papillomavirus vaccination reached 82.1% by 2023, lowering rates among both unvaccinated and vaccinated individuals.

A little over half of teens are currently vaccinated against HPV, while Healthy People 2030 has set the goal to 80% of US ...

Cervical cancer remains one of the most preventable yet deadly cancers for women worldwide, with vast disparities between high-income nations and ...

New research using genetic data has uncovered causal links between common viral infections and several psychiatric disorders.

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.

Boston, USA-based Bicara Therapeutics, a biotech focused on developing bifunctional therapies for solid tumors, announced ...

Ficerafusp alfa is currently being evaluated in FORTIFI-HN01, a pivotal Phase 2/3 clinical trial in patients with first line (1L) recurrent/metastatic (R/M) head and neck squamous cell carcinoma ...

The WHO strategic plan for elimination of cervical cancer and how a combination of prevention, screening, and treatment can ...

Cancer screenings are a vital part of a woman’s reproductive and overall health. While breast cancer is the most common reproductive cancer in women, cervical cancer is the third most common type of ...

Health officials in Yilo Krobo say some parents are stopping their daughters from receiving the free Human Papillomavirus ...